This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

ThermoGenesis, Power-One: Early Volume Plays

NEW YORK ( TheStreet) -- Several stocks trading near $5 were poised to move on above-average volume during Friday's session.

ThermoGenesis (KOOL - Get Report) should trade sharply higher Friday after the medical device maker announced a new enhanced distribution agreement with GE Healthcare, a unit of General Electric (GE - Get Report), for its AXP AutoXpress System used in the processing of cord blood. The announcement came as ThermoGenesis reported fiscal second-quarter earnings that ere unchanged from the year-ago quarter. The 50-day average daily volume for ThermoGenesis is 194,000, according to the Nasdaq. Shares closed Thursday at 51 cents and were up nearly 18% in the after-market session.

Power-One (PWER - Get Report) should rally more than 20% Friday after the power conversion company posted a fourth-quarter profit of 5 cents a share, which surprised analysts who had expected a loss of 3 cents a share in the quarter. Revenue was up 9% to $142 million, also well ahead of forecasts. The 50-day average daily volume for Power-One is 1.17 million. The stock finished Thursday at $3.10 and surged 22.3% in late trading.

Powerwave Technologies (PWAV) jumped by 56 cents, or 25%, to $2.80 in the premarket session after the wireless solutions company reported a fourth-quarter profit of a penny a share, disappointing analysts who had expected earnings of 3 cents a share, according to Thomson Reuters. Revenue of $142.6 million was down 21% from a year ago and below the $148.3-million consensus. The 50-day average daily volume for is 918,000. Shares ended trading Thursday at $1.35 and were down 11.1% in the after-hours session.

EntreMed (ENMD) shares were indicated to open lower after the pharmaceutical company said late Thursday it has completed a registered direct offering of 3.84 million shares of its common stock, at a purchase price of 65 cents per share, to a single accredited institutional investor. Shares closed Thursday at 70 cents and were down 7.1% in late trading. The 50-day average daily volume for EntreMed is 323,000.

-- Written by Robert Holmes in Boston.

Check out all of Friday's high-volume, under-$5 stocks at the Dollar Store

Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs